在COVID-19患者的托西利祖马布治疗:治疗的副作用和对死亡率的影响
1Department of Anesthesiology, Izmir Democracy University, Izmir, Turkey. pinar.ayvat@idu.edu.tr.
European review for medical and pharmacological sciences
|March 18, 2024
概括
托西利祖马布在COVID-19患者的使用没有显著影响死亡率,尽管观察到短期副作用. 这项研究发现,这种干白素-6抑制剂治疗对长期死亡率没有好处.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 托西利祖马布 (tocilizumab) 是一种互白素-6 (IL-6) 受体对手,已被研究其在治疗严重的COVID-19时的潜在益处.
- 最初的研究表明死亡率可能有所降低,但随后的元分析产生了相互矛盾的结果.
- 了解托西利祖马布在COVID-19患者中的疗效和安全性,对于临床决策至关重要.
研究的目的:
- 评估托西利祖马布对COVID-19重症监护室 (ICU) 患者死亡率的影响.
- 为了确定和评估与托西利祖马布在这个患者群体中管理相关的潜在副作用.
- 分析影响托西利祖马布治疗组和对照组死亡率的因素.
主要方法:
- 一项涉及COVID-19的ICU患者的比较研究设计,分为托西利祖马布和对照组.
- 在多个时间点 (0,3,7,14天) 收集人口,临床,实验室 (血液图,生物化学,急性阶段反应物) 和微生物学数据.
- 统计分析检查死亡率因素和群体之间和群体内的副作用,考虑APACHE评分.
主要成果:
- 在托西利祖马布和对照组之间没有观察到统计学上显著的死亡率差异,即使在托西利祖马布组的APACHE得分较低.
- 在托西利祖马布组中观察到的短期副作用包括第3天氨酸转移酶和的升高,并在第7天降低了血小板,葡萄糖和凝血参数.
- 在托西利祖马布组中,在第3天和第7天观察到较低的前素,C-反应蛋白和纤维素原水平. 额外的疾病和阳性培养增加了托西利祖马布组的死亡风险.
结论:
- 托西利祖马布治疗没有对COVID-19患者的长期死亡率产生显著影响.
- 托西利祖马布已知的副作用是在短期使用期间观察到的.
- 虽然托西利祖马布是用于COVID-19的IL-6抑制剂,但包括本研究在内的当前证据并不一致支持其用于降低死亡率.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
COPD: Management Using Bronchodilators and Corticosteroids
205
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
205
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
245
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
245
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
Skeletal Muscle Relaxants: Adverse Effects
369
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
369
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

